The 2024 EU Drug Market Analysis Report, published by the European Union Drugs Agency (EUDA), provides a comprehensive overview of the current state of drug markets across Europe. This strategic report delves into the production, trafficking, and consumption patterns of various substances, highlighting emerging trends and challenges. A significant focus is placed on the rise of new psychoactive substances (NPS), with ketamine being notably prevalent in certain regions. The report also examines the increasing complexity of drug distribution networks, the role of digital platforms in facilitating drug trade, and the associated rise in drug-related violence. These insights are crucial for informing policy decisions and enhancing collaborative efforts to address the evolving drug landscape in Europe.
- Journal Name:
- European Monitoring Centre for Drugs and Drug Addiction
- Publication Date:
- 7 March 2024
In conclusion, the 2024 EU Drug Market Analysis underscores the dynamic nature of Europe's drug markets, emphasizing the need for adaptive strategies and strengthened international cooperation to effectively combat drug-related challenges.
EU Drug Market Analysis 2024
Europe's illicit drug market is valued at over €31 billion, with high availability across all drugs.
Tags: